VOXYVOTE

FDA Panel Recommends Pulling Preterm Birth Drug From the Market

Written by

Christina Jewett

in

The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.

Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More posts